Today marks a pivotal moment in Injective’s journey toward mainstream adoption as Canary Capital, a leading digital asset fund manager, officially filed with the U S Securities and Exchange Commission to launch the Canary Staked INJ ETF, the first exchange traded fund to offer regulated exposure to staked INJ, the native token of Injective.
As of now, INJ is one of the only major assets with an official ETF filing with the SEC. The proposed Canary ETF would provide retail and institutional investors with direct exposure to staked INJ through a regulated investment vehicle, effectively bridging the gap between traditional and onchain finance.
Background on Canary Capital
The timing of this filing is particularly significant. Canary Capital has established itself as a pioneer in the crypto ETF space, having submitted applications for only a select few digital asset ETFs including XRP and Solana. The broader market is showing surging appetite with spot Bitcoin funds pulling in 1.18 billion dollars of net inflows in a single day on July 10, 2025 and ETH ETFs seeing 703 million dollars in a single week. This expansion strategy demonstrates the firm’s commitment to bringing institutional grade access to promising blockchain ecosystems.
Institutional Momentum Behind INJ
The timing of the ETF filing also coincides with Injective's expanding engagement with regulators and policymakers. Injective Labs recently submitted a comprehensive policy comment to the SEC's Crypto Task Force, addressed directly to Commissioner Hester Peirce, outlining a pragmatic framework for regulating DeFi protocols without stifling innovation. This proactive approach to regulatory engagement demonstrates Injective's commitment to responsible growth within the evolving regulatory landscape.
The filing comes as Injective continues to strengthen its position in the institutional landscape. Recent developments include the addition of major players such as Google Cloud, T-Mobile and BitGo, the world's largest staking platform with over $100 billion in institutional trust, as an Injective Council members. This institutional-grade infrastructure provides the foundation necessary for products like ETFs to operate with the security and reliability that traditional investors demand.
Crypto Week in Congress: A Game-Changing Regulatory Framework
This filing comes at the most critical point in the American political system regarding digital assets. The week has been dubbed Crypto Week in Congress as lawmakers take up three landmark bills that could define the future of the industry:
- CLARITY Act — defines whether tokens are securities or commodities and sets clear oversight roles for the SEC and CFTC
- GENIUS Act — creates the first federal framework for payment stablecoins, requiring full reserves and transparency
- Anti‑CBDC Surveillance State Act — prohibits the Federal Reserve from issuing a retail central bank digital currency
Together these three bills mark a historic legislative push to define the rules of the road for staking, token classification, stablecoin integrity, and digital privacy. Their progress during Crypto Week will determine whether Injective’s Canary Staked INJ ETF and similar products can move forward within a stable, regulated framework.
Increasing Injective Adoption Among Institutional Circles
This announcement follows Injective's successful track record with compliant investment vehicles. The European launch of 21Shares's AINJ exchange-traded earlier demonstrated strong demand for regulated Injective investment vehicles. The U.S. market, with its deeper capital pools and more sophisticated institutional infrastructure, represents an even greater opportunity for Injective adoption.
The staked nature of the proposed ETF is particularly noteworthy. Unlike traditional crypto ETFs that simply hold tokens, this product would actively participate in Injective's proof-of-stake consensus mechanism, generating staking rewards for investors while contributing to network security. This approach aligns perfectly with Injective's vision of creating sustainable, economically aligned incentives for network participants.
Looking Forward: The Future of Finance
As Eric Chen, Co-Founder of Injective, noted in response to the filing:
"Injective was purpose-built to unite traditional and decentralized finance. This ETF integrates staking into a regulated format, giving both institutions and individuals secure access to the new future of finance"
The Canary Staked INJ ETF represents more than just a new investment product; it's a bridge between the traditional financial system and the decentralized future that Injective is building. By providing regulated access to staked INJ, this ETF could introduce a new generation of investors to the benefits of blockchain technology while maintaining the security and compliance standards they expect.
As the digital asset ecosystem continues to mature and regulatory frameworks like the CLARITY Act provide much-needed transparency, products like the Canary Staked INJ ETF will play a crucial role in bringing institutional capital to the most innovative blockchain networks. For Injective, this represents another significant milestone in the journey toward mainstream adoption and the realization of its vision as the premier destination for institutional-grade onchain finance.
The future of finance is being written today, and with the Canary Staked INJ ETF, Injective continues to lead the charge toward a more open, accessible, and efficient financial system for everyone.
Read the full SEC ETF filing for INJ on their official website: Here
About Injective
Injective is a lightning fast interoperable layer one blockchain optimized for building premier Web3 finance applications. Injective provides developers with powerful plug-and-play modules for creating unmatched dApps. INJ is the native asset that powers Injective and its rapidly growing ecosystem. Injective is incubated by Binance and is backed by prominent investors such as Jump Crypto, Pantera and Mark Cuban.
Website | Telegram | Discord | Blog | Twitter | Youtube | Facebook |LinkedIn | Reddit | Instagram | Orbit Newsletter
